Gendaq Says Zinc Finger Platform Ready For Regulation Of Genes

RiboTargets Signs Deal With J&J, Plans Financing Round Of £20M

Oxford BioMedica Seeks £40M As It Moves To London Exchange

Gendaq Says Zinc Finger Platform Ready For Regulation Of Genes

RiboTargets Signs Deal With J&J, Plans Financing Round Of £20M

Oxford BioMedica Seeks £40M As It Moves To London Exchange

Celltech Getting $50M Up Front In $230M Pharmacia Collaboration

CellFactors Gains Broad Patent In U.S. Covering CNS Cell Lines

Government Helps London Centers Spin Off Companies

PPL Says Disease In UK Should Not Affect Clones